Matches in Wikidata for { <http://www.wikidata.org/entity/Q38092916> ?p ?o ?g. }
- Q38092916 description "article científic" @default.
- Q38092916 description "article scientifique" @default.
- Q38092916 description "articol științific" @default.
- Q38092916 description "articolo scientifico" @default.
- Q38092916 description "artigo científico" @default.
- Q38092916 description "artigo científico" @default.
- Q38092916 description "artigo científico" @default.
- Q38092916 description "artikel ilmiah" @default.
- Q38092916 description "artikull shkencor" @default.
- Q38092916 description "artículo científico" @default.
- Q38092916 description "artículu científicu espublizáu en 2013" @default.
- Q38092916 description "bilimsel makale" @default.
- Q38092916 description "scienca artikolo" @default.
- Q38092916 description "scientific article published on 26 March 2013" @default.
- Q38092916 description "scientific article published on 26 March 2013" @default.
- Q38092916 description "scientific article published on 26 March 2013" @default.
- Q38092916 description "vedecký článok" @default.
- Q38092916 description "vetenskaplig artikel" @default.
- Q38092916 description "videnskabelig artikel" @default.
- Q38092916 description "vitenskapelig artikkel" @default.
- Q38092916 description "vitskapeleg artikkel" @default.
- Q38092916 description "vědecký článek" @default.
- Q38092916 description "wetenschappelijk artikel" @default.
- Q38092916 description "wissenschaftlicher Artikel" @default.
- Q38092916 description "наукова стаття, опублікована в березні 2013" @default.
- Q38092916 description "научная статья" @default.
- Q38092916 description "научни чланак" @default.
- Q38092916 description "מאמר מדעי" @default.
- Q38092916 description "مقالة علمية نشرت في 26 مارس 2013" @default.
- Q38092916 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38092916 name "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 name "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 name "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 type Item @default.
- Q38092916 label "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 label "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 label "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 prefLabel "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 prefLabel "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 prefLabel "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 P1433 Q38092916-5D5482AE-35D5-4634-BC81-D5FCB66A1C1F @default.
- Q38092916 P1476 Q38092916-4980FDBE-F152-46DD-BA62-0EF1F4307E2D @default.
- Q38092916 P2093 Q38092916-21D98CCE-CA0C-452B-8D57-44A19D01229B @default.
- Q38092916 P2093 Q38092916-2938E816-7D62-46C2-8D51-0832CAE783A3 @default.
- Q38092916 P2093 Q38092916-4936AE58-5B69-47DB-970F-51C6B13B6584 @default.
- Q38092916 P2093 Q38092916-81982F7E-57CA-4650-9DF3-97B442682012 @default.
- Q38092916 P2093 Q38092916-89CBEB04-3BC0-4110-8DBB-D62D91B21F2B @default.
- Q38092916 P2093 Q38092916-8E76AC27-3EE7-4A40-B7F8-524774035C41 @default.
- Q38092916 P2093 Q38092916-DF3CE715-8ACF-46F5-8413-89D75EA26818 @default.
- Q38092916 P2093 Q38092916-F30BB54E-C381-46FD-A348-CCB2C0A4E340 @default.
- Q38092916 P2093 Q38092916-FED0AC95-142D-438E-A80A-094F33D80202 @default.
- Q38092916 P2860 Q38092916-01417D31-3BFE-40C2-8BD5-FEBA10510021 @default.
- Q38092916 P2860 Q38092916-027E8479-B4AD-4FC5-8CB6-68BB396657A8 @default.
- Q38092916 P2860 Q38092916-27F94B87-DDFF-4238-9FC5-C38DDE16BBC0 @default.
- Q38092916 P2860 Q38092916-2B68799B-49F0-4DAE-AAA0-C708D19635C8 @default.
- Q38092916 P2860 Q38092916-2D4EF9BE-DF1A-43B7-B7AA-E73D7B5B8452 @default.
- Q38092916 P2860 Q38092916-4A7C2AF0-F9BD-4A88-BFD0-FBA0A4149589 @default.
- Q38092916 P2860 Q38092916-4CE650A8-9B35-45C0-9BE0-05674C32FA72 @default.
- Q38092916 P2860 Q38092916-6E0D9CE6-3DC0-4DA8-B92D-75675198D97F @default.
- Q38092916 P2860 Q38092916-8292ACFA-BCF2-4555-958D-F663754C6CB5 @default.
- Q38092916 P2860 Q38092916-9107350D-5D76-495E-A7AD-AF0925BA1DB2 @default.
- Q38092916 P2860 Q38092916-A90D956F-C0AA-4A4C-8E1D-9B86C905DAFF @default.
- Q38092916 P2860 Q38092916-AF2FE116-8EE1-4706-B9B5-0E162654A311 @default.
- Q38092916 P2860 Q38092916-DC5AB6A4-C52F-4F62-83EE-4B19E8829B42 @default.
- Q38092916 P2860 Q38092916-E8639FCC-6C95-434D-A6C3-F2991A873B4E @default.
- Q38092916 P2860 Q38092916-F6061F2A-4F7E-4BE0-8220-9482373F5647 @default.
- Q38092916 P304 Q38092916-75117240-2D79-4BEF-ADD6-A0C623C3BBB0 @default.
- Q38092916 P31 Q38092916-C51C568A-ECBD-40C3-9FDC-37E74BB72AA1 @default.
- Q38092916 P356 Q38092916-7392076B-E7DB-4AA2-B28B-4B741A767B1F @default.
- Q38092916 P433 Q38092916-35C6CAFC-1BF2-4449-82BB-C094A5F571CD @default.
- Q38092916 P478 Q38092916-F66D18B8-6B1D-48C3-BCA7-9ADE83F056EE @default.
- Q38092916 P50 Q38092916-7D7C211C-338E-41A7-8496-D6FF95AA1740 @default.
- Q38092916 P577 Q38092916-1D2DC8DC-566B-4410-B805-7792A967BBB0 @default.
- Q38092916 P698 Q38092916-707EA6DF-171B-4371-BCF7-8EDB2CAB8AA6 @default.
- Q38092916 P921 Q38092916-6663A2F0-FD17-4D46-A270-5B62B88D6E9A @default.
- Q38092916 P921 Q38092916-9E99CA18-4CCE-4805-927A-8A9C1BD34DCC @default.
- Q38092916 P921 Q38092916-A4C8570C-511E-447A-9126-D90DA156E12E @default.
- Q38092916 P356 TBJ.12098 @default.
- Q38092916 P698 23528159 @default.
- Q38092916 P1433 Q15749274 @default.
- Q38092916 P1476 "A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines" @default.
- Q38092916 P2093 "Fawzia Mefti" @default.
- Q38092916 P2093 "Florence Lefresne" @default.
- Q38092916 P2093 "Maria Konstantinova" @default.
- Q38092916 P2093 "Mario Campone" @default.
- Q38092916 P2093 "Nadege Meheust" @default.
- Q38092916 P2093 "Natalya Dobrovolskaya" @default.
- Q38092916 P2093 "Sameul Fourie" @default.
- Q38092916 P2093 "Serjei Tjulandin" @default.
- Q38092916 P2093 "Shin-Chen Chen" @default.
- Q38092916 P2860 Q27860904 @default.
- Q38092916 P2860 Q34524041 @default.
- Q38092916 P2860 Q36072097 @default.
- Q38092916 P2860 Q36501708 @default.
- Q38092916 P2860 Q36509680 @default.
- Q38092916 P2860 Q37287394 @default.
- Q38092916 P2860 Q37329165 @default.
- Q38092916 P2860 Q37382271 @default.
- Q38092916 P2860 Q40530849 @default.
- Q38092916 P2860 Q40717836 @default.